Moderna (MRNA) EPS (Basic) (QoQ) (2018 - 2026)
Moderna (MRNA) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.12% |
| Dec 31, 2025 | -314.06% |
| Sep 30, 2025 | 75.88% |
| Jun 30, 2025 | 15.47% |
| Mar 31, 2025 | 13.75% |
| Dec 31, 2024 | -8,737.82% |
| Sep 30, 2024 | 101.01% |
| Jun 30, 2024 | -8.28% |
| Mar 31, 2024 | -641.47% |
| Dec 31, 2023 | 105.96% |
| Sep 30, 2023 | -163.04% |
| Jun 30, 2023 | -1,869.76% |
| Mar 31, 2023 | -94.50% |
| Dec 31, 2022 | 39.03% |
| Sep 30, 2022 | -51.80% |
| Jun 30, 2022 | -39.01% |
| Mar 31, 2022 | -24.69% |
| Dec 31, 2021 | 46.42% |
| Sep 30, 2021 | 19.30% |
| Jun 30, 2021 | 126.55% |